llm_output,best_matching_ground_truth,best_evaluation,best_score
Selective Serotonin Reuptake Inhibitor antidepressants first-line treatment Major Depressive Disorder,Bupropion Properties Norepinephrine and dopamine reuptake inhibitor,"Score: 0.50
The LLM output is incorrect as it provides information about Selective Serotonin Reuptake Inhibitors and Major Depressive Disorder, which is not related to Bupropion being a norepinephrine and dopamine reuptake inhibitor.",0.5
SSRIs More commonly used Major Depressive Disorder,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output partially captures the idea that SSRIs are commonly used in Major Depressive Disorder, but it does not accurately represent the comparison with bupropion in terms of activation profile and superiority in some MDD patients.",0.5
Monoamine Oxidase Inhibitors Less commonly used Major Depressive Disorder,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct but includes additional information not present in the ground truth statement.",0.75
Vagus Nerve Stimulation Treats resistant unilateral or bipolar depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but includes additional information about specific types of depression treated by Vagus Nerve Stimulation, which was not mentioned in the ground truth statement.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment All Depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output mentions a specific type of treatment (SSRIs) for depression, which is incorrect as the ground truth only states that depression can have a slower response to treatment, not specifying any particular treatment method.",0.75
Depression-focused psychotherapy second-line treatment Major Depressive Disorder,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output slightly misinterpreted the ground truth by saying ""Major Depressive Disorder"" instead of ""Acute phase depression"", but overall conveyed a similar idea.",0.75
Electroconvulsive therapy Treats Depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output is mostly correct, but it oversimplifies the range of treatment options available for acute-phase depression by solely focusing on electroconvulsive therapy.",0.75
"Anxious Depression more common than nonanxious depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less Education, Public insurance, Lower-income",Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not related to the Ground Truth statement, making it half correct.",0.5
"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is an exact match to the ground truth, indicating a perfect score for overall correctness.",1.0
Mirtazapine Comparable to SSRIs in efficacy,Mirtazapine As effective as SSRIs,"Score: 0.95
The LLM output is almost identical to the Ground Truth statement, with the only difference being the choice of words ""as effective"" vs ""comparable in efficacy.""",0.95
Physical exercise Treats All Depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.60
The LLM output is not entirely correct as it simplifies the relationship between physical exercise and depression, whereas the ground truth acknowledges exercise as an adjunct to other treatments for depression.",0.6
Depression-focused psychotherapy second-line treatment All Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct, but it incorrectly states that depression-focused psychotherapy is all-encompassing for depression treatment rather than being specifically for the acute phase.",0.75
Electroconvulsive therapy (ECT) Highly effective somatic therapy for depression in some specific situations,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.90
The LLM output is slightly different from the ground truth by adding ""highly"" and ""somatic therapy,"" but overall it maintains the main idea accurately.",0.9
Ketamine Properties very quick effects on resistant unipolar depression and acute suicidal ideation,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output correctly mentions Ketamine's effects on depression and suicidal ideation but does not directly relate it to the concept of ""side effect"".",0.75
Selective Serotonin Reuptake Inhibitor antidepressants first-line treatment Major Depressive Disorder during the acute phase,SSRIs Treat Acute phase of depression,"Score: 0.90
The LLM output is mostly correct, but it includes additional information and alternative wording that does not match the exact wording of the ground truth.",0.9
Major Depressive Disorder Definition a prevalent psychiatric disorder that often leads to poor quality of life and impaired functioning,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.75
The LLM output is mostly incorrect as it defines Major Depressive Disorder instead of addressing the goal of mindfulness-based cognitive therapy, but it does mention it's a prevalent psychiatric disorder which is somewhat related.",0.75
Physical exercise Associated with improvement in depression symptom and prevention of relapses,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
Physical exercise is associated with improvement in depression symptoms and prevention of relapses, but pharmacotherapy is the recommended treatment for the acute phase of depression.",0.75
All Depression Associated with high rates of suicidal behavior and mortality,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output is mostly correct as it correctly associates depression with suicidal behavior, but does not specify it as a side effect and oversimplifies the relationship between depression, suicidal behavior, and mortality.",0.75
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output lists various antidepressants as more effective, which matches the overall theme of the ground truth statement about rTMS and antidepressants being effective, but there are discrepancies in the specific medications listed.",0.75
"Combination of medication, psychotherapy, and somatic therapy Treats resistant form of depression",Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct as it mentions a combination of medication and psychotherapy, but it does not specifically mention family therapy, and it uses the term ""resistant form of depression"" instead of severe forms associated with hospitalization.",0.75
Reboxetine Less effective All other antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies Reboxetine as less effective compared to other antidepressants, but it does not specifically mention repetitive Transcranial Magnetic Stimulation (rTMS).",0.75
All Depression Definition a prevalent psychiatric disorder that often leads to poor quality of life and impaired functioning,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is somewhat related to the ground truth as it mentions depression and its impact on quality of life, but it does not directly address the specific topic of depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.75
Psychoeducation Goal educate depressed patients and family members about depression symptoms and management,Psycho-education Goal Educates depressed patients and family members involved in the patient’s life about depression symptoms and management,"Score: 0.95
The LLM output is almost identical to the ground truth statement, with just a minor difference in wording.",0.95
"Escitalopram and Sertraline Better acceptability Duloxetine, Fluvoxamine, Paroxetine, Reboxetine, Venlafaxine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50

The LLM output correctly identifies some SSRI medications but also includes non-SSRI medications in the list, decreasing the overall correctness score.",0.5
"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output perfectly matches the ground truth statement with no errors or deviations.",1.0
Escitalopram and Sertraline Highly effective Unipolar major depression,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct in conveying that antidepressants like Escitalopram and Sertraline are highly effective for unipolar major depression, but it does not specifically mention repetitive Transcranial magnetic stimulation (rTMS) or compare the effectiveness of rTMS and antidepressants as stated in the ground truth.",0.75
Electroconvulsive therapy Definition the most effective somatic therapy for depression in specific situations,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.85
The LLM output is mostly correct but slightly exaggerates the effectiveness of electroconvulsive therapy for depression.",0.85
Major Depressive Disorder Definition a prevalent psychiatric disorder leading to poor quality of life and impaired functioning,"Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.75
The LLM output misses important aspects of depression-focused psychotherapy, such as monitoring mood, understanding symptoms, and practical coping tools, resulting in a less complete and accurate description.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depressive Disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is mostly correct but it incorrectly suggests SSRIs as the first-line treatment for Major Depressive Disorder rather than Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
"SSRIs Side effects sexual dysfunction, loss of appetite, vomiting, nausea, irritability, anxiety, insomnia, and headache",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output slightly detracts from the overall correctness due to not directly addressing the comparison made in the Ground Truth statement.",0.75
Escitalopram and Sertraline first-line treatment Moderate to severe major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct as it correctly identifies Escitalopram and Sertraline as first-line treatments for major depression, but it inaccurately states that they are the only treatments and does not mention the role of psychotherapy.",0.75
Compared antidepressants Treatment options Acute treatment of unipolar major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output slightly paraphrases the ground truth by mentioning antidepressants as a treatment option for the acute phase of depression, but the overall message is still accurate.",0.75
Ketamine Treats resistant unipolar and possibly bipolar depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but includes additional information about specific types of depression.",0.75
"Escitalopram and Sertraline Overview Good balance between benefits, acceptability, and acquisition cost for moderate to severe major depression",Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is mostly correct in identifying medications (Escitalopram and Sertraline) commonly used for moderate to severe major depression, but it misinterprets the ground truth of depression-focused psychotherapy for mild to moderate MDD.",0.75
"Resistant forms of depression Treats Combination of medication, psychotherapy, and somatic therapy",Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct, but it inaccurately describes the treatment of severe depression as ""resistant forms"" and does not mention hospitalization.",0.75
Exercise Recommended as adjunct to treat Major Depressive Disorder,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.90
The LLM output captures the essence of the ground truth statement accurately, but with some slight differences in wording.",0.9
"Ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is identical to the ground truth, resulting in a perfect score for overall correctness.",1.0
Cognitive Behavioral Therapy and Interpersonal Therapy first-line treatment Mild to moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.85
The LLM output is mostly correct but uses slightly different terminology for the same treatment approach.",0.85
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used due to side effects such as hepatotoxicity and hypertensive crisis,Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.90
The LLM output is overall correct as it accurately conveys that monoamine oxidase inhibitors are less commonly used due to side effects such as hepatotoxicity and hypertensive crisis, matching the ground truth statement.",0.9
Electroconvulsive Therapy (ECT) Highly effective for Major Depressive Disorder,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as a treatment option for Major Depressive Disorder, but it oversimplifies by not acknowledging other effective treatment approaches mentioned in the ground truth statement.",0.75
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine for Unipolar Major Depression in adults","Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output provides relevant information about treatments for depression in adults, but it does not directly address the focus on preventing depression among the elderly and treating mild depressive symptoms in primary care settings mentioned in the Ground Truth.",0.75
Tricyclic antidepressants (TCAs) More effective than SSRIs in hospitalized patients with severe Major Depressive Disorder symptoms,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output, while relevant to comparing antidepressants, does not directly address the statement comparing monoamine oxidase inhibitors and tricyclic antidepressants in terms of efficacy.",0.75
Cognitive-Behavioral Therapy (CBT) first-line treatment Mild to Moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.80
The LLM output captures the essence of the ground truth statement but does not include the term ""depression-focused psychotherapy"" and uses ""CBT"" instead.",0.8
Major Depressive Disorder Definition a prevalent psychiatric disorder leading to poor quality of life and impaired functioning,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM output is mostly correct in defining Major Depressive Disorder, but it does not accurately address the comparison between transcranial direct current stimulation, antidepressants, and rTMS as mentioned in the ground truth.",0.75
Phototherapy Effective for both seasonal and non-seasonal depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.80
LLM Output correctly summarizes the main idea of the Ground Truth statement, but does not mention the benefits to sleep deprivation and drug treatments that have been reported.",0.8
Reboxetine less effective All other tested antidepressants for Unipolar Major Depression in adults,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is somewhat correct as it mentions the effectiveness of reboxetine compared to other antidepressants for unipolar major depression in adults, although it does not accurately capture the ground truth statement about electroconvulsive therapy being effective in some situations for acute phase depression.",0.75
Interpersonal Therapy (IPT) first-line treatment Mild to Moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.95
The LLM output is almost identical to the ground truth, with the only difference being the specific type of therapy recommended.",0.95
New-generation antidepressants Associated with Inconsistency in results regarding efficacy,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct but not directly addressing the comparison between MAOIs and tricyclic antidepressants, leading to a slightly lower score.",0.75
Sertraline first-line treatment Moderate to severe major depression in adults,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output is partially correct as it mentions sertraline as a first-line treatment for moderate to severe major depression, but it does not fully capture the specific efficacy of monoamine oxidase inhibitors in treating atypical features.",0.5
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is somewhat correct in acknowledging that SSRIs are a common treatment for depression, but it does not directly address the slower response to treatment as stated in the ground truth.",0.75
Electroconvulsive therapy (ECT) Highly effective Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct but lacks the specific mention of its effectiveness in the acute phase of depression and in some situations.",0.75
Depression-focused psychotherapy second-line treatment Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.90
The LLM output is mostly correct but the term ""second-line treatment"" is not exactly the same as ""second most common treatment"" in the Ground Truth.",0.9
MAOIs Specific efficacy in treating Depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.85
The LLM output is mostly correct as it captures the main idea of the ground truth statement, but is slightly less detailed.",0.85
SSRIs side effects sexual and digestive issues,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is only partially correct as it mentions some side effects of SSRIs but does not provide any information on the statement regarding Bupropion and its effectiveness in improving symptoms of fatigue and sleepiness.",0.5
"Escitalopram and Sertraline More favorable Profile of acceptability leading to significantly fewer discontinuations than Duloxetine, Fluvoxamine, Paroxetine, Reboxetine, and Venlafaxine","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is mostly correct in comparing the acceptability profiles of different antidepressants, but it does not address the specific efficacy of monoamine oxidase inhibitors in treating atypical features.",0.75
Second-generation antidepressants Associated with inconsistencies in efficacy results,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is not fully correct as it inaccurately describes the efficacy of second-generation antidepressants, which are not specifically mentioned in the ground truth statement.",0.75
"Ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output matches the ground truth statement exactly, resulting in a perfect score for overall correctness.",1.0
Sertraline and Escitalopram Highly effective Acute treatment of major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but lacks specificity in mentioning only two medications when there are many others available for treating the acute phase of depression.",0.75
Cognitive-Behavioral Therapy (CBT) first-line treatment Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct with the mention of Cognitive-Behavioral Therapy (CBT) as a first-line treatment for depression, but it inaccurately states that it is the most common treatment during the acute phase when it is actually the second most common.",0.75
Interpersonal Therapy (IPT) first-line treatment Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output correctly identifies Interpersonal Therapy (IPT) as a first-line treatment for depression, but does not mention that it is the second most common treatment during the acute phase.",0.75
Depression Associated with poor quality of life and impaired functioning,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.80
LLM Output is somewhat related to Ground Truth in terms of discussing depression and its impact, but does not directly address the comparison of transcranial direct current stimulation results with antidepressants and rTMS.",0.8
Reboxetine Less effective than all the other tested antidepressants for treating Major Depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output correctly states that Reboxetine is less effective than other tested antidepressants for treating Major Depression, but it does not directly address the statement about Monoamine oxidase inhibitors being eligible for patients who do not respond to other treatments.",0.75
"Mirtazapine, Escitalopram, Venlafaxine, and Sertraline More effective than Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, and Reboxetine for treating Major Depression","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output correctly identifies different antidepressants and their efficacy in treating Major Depression, but does not directly address the specific efficacy of monoamine oxidase inhibitors in treating Atypical features.",0.75
Acute treatment duration for Major Depression Definition 8-week treatment period,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it correctly identifies that the treatment duration for Major Depression is 8 weeks, but doesn't explicitly mention SSRIs and the acute phase of depression.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depressive Disorder during the acute phase,SSRIs Treat Acute phase of depression,"Score: 0.95
The LLM output is almost identical to the ground truth statement, with the only difference being the addition of ""Major Depressive Disorder"" which does not change the overall meaning or correctness of the statement.",0.95
Depression-focused psychotherapy second-line treatment Major Depressive Disorder,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output correctly identifies depression-focused psychotherapy as a treatment for Major Depressive Disorder, but incorrectly labels it as second-line treatment instead of the second most common treatment for Acute phase depression.",0.75
Monoamine Oxidase Inhibitors (MAOIs) less commonly used antidepressants,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct in identifying monoamine oxidase inhibitors (MAOIs) as antidepressants, but the statement about their frequency of use is not entirely accurate.",0.75
"SSRIs side effects sexual and digestive issues, irritability, anxiety, insomnia, and headaches",Nefazodone Side effects Rare cases of clinical idiosyncratic hepatotoxicity,"Score: 0.75
The LLM output contains relevant information about SSRIs side effects but does not directly address the information from the ground truth about Nefazodone.",0.75
Escitalopram Comparable to Sertraline in terms of efficacy and acceptability for the treatment of major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but does not specifically mention the acute phase of depression, hence the slight deduction in score.",0.75
Electroconvulsive therapy (ECT) highly effective somatic therapy for Depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output correctly identifies electroconvulsive therapy (ECT) as a somatic therapy for depression, but does not mention other acute-phase treatment options.",0.8
Major Depressive Disorder Symptom high rates of suicidal behavior and mortality,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output accurately identifies the relationship between depression and suicidal behavior but misses some specificity in terms of side effects.",0.75
"Major Depression Definition a mental health disorder characterized by a pervasive and persistent low mood, accompanied by low self-esteem and loss of interest or pleasure in normally enjoyable activities","Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.85
The LLM output provides a fairly accurate definition of major depression but does not fully capture the multifaceted goals and approach of depression-focused psychotherapy as outlined in the ground truth.",0.85
Tricyclic antidepressants (TCAs) more effective than SSRIs in hospitalized patients,Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in comparing two types of antidepressants, but it incorrectly mentions TCAs instead of mirtazapine as being more effective than SSRIs.",0.75
Sertraline Comparable to escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The score is low because the LLM output does not match the ground truth in terms of the specific drugs mentioned.",0.5
"Mirtazapine, escitalopram, venlafaxine, sertraline More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output provides a list of antidepressants without specifying their effectiveness, which does not directly match the statement about rTMS and antidepressants being more effective.",0.5
"Mirtazapine, venlafaxine Highly effective Major depressive disorder treatment","Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.25
The LLM output is not correct as it incorrectly states that mirtazapine and venlafaxine are highly effective for the treatment of major depressive disorder, when the ground truth is focused on the goal of mindfulness-based cognitive therapy for reducing or stopping antidepressant treatment.",0.25
"Escitalopram and sertraline More tolerable duloxetine, fluvoxamine, paroxetine, reboxetine",Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output provides information on the tolerability of different medications, but does not directly address the comparison on improving symptoms of fatigue and sleepiness.",0.75
Reboxetine Less effective All the other 11 antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies Reboxetine as less effective compared to the other 11 antidepressants but does not mention rTMS, which was found to be more effective in the ground truth statement.",0.75
Sertraline Widely used Treatment for Major depressive disorder,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.50
The LLM output is partially correct but does not provide a comprehensive or accurate representation of the ground truth statement.",0.5
Ketamine specific efficacy in treating resistant unipolar and bipolar depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.80
The LLM output is mostly correct as it specifies the efficacy of Ketamine in treating resistant unipolar and bipolar depression, which aligns with the Ground Truth statement. However, the LLM output could be more precise by mentioning that Ketamine has effects on both types of depression rather than just stating its efficacy.",0.8
Major Depressive Disorder Definition a prevalent psychiatric disorder leading to poor quality of life and impaired functioning,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output provides a general definition of major depressive disorder but does not accurately capture the specific treatment approach of cognitive-behavioral therapy for depressed patients with irrational beliefs and distorted cognitions.",0.75
"Escitalopram and Sertraline Properties Show the best profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine","Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output provides information about the acceptability of certain antidepressants, but does not directly address the specific efficacy of monoamine oxidase inhibitors in treating atypical features.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment All Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct as SSRIs are commonly used as a first-line treatment for depression, but it is not entirely accurate to say they are the only treatment for all types of depression.",0.75
Cognitive-behavioral therapy (CBT) first-line treatment Major Depressive Disorder,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct as it correctly identifies CBT as a treatment for Major Depressive Disorder, but it does not fully capture the range of therapies included in depression-focused psychotherapy.",0.75
Bupropion Properties minimal weight gain or even weight loss,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.75
The LLM output is largely correct as it mentions minimal weight gain or even weight loss, which aligns with the Ground Truth statement.",0.75
MAOIs Specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.90
The LLM output is mostly correct, but it is slightly more general and lacks some specific details mentioned in the ground truth statement.",0.9
Psychotherapy first-line treatment mild to moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.80
The LLM output captures the essence of the ground truth but has some slight inaccuracies in the wording.",0.8
Reboxetine Not effective First-line acute treatment for major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in stating that Reboxetine is not effective as a first-line treatment for major depression, but it does not completely align with the ground truth in terms of pharmacotherapy treating the acute phase of depression.",0.75
Ketamine Treats treatment-resistant unipolar and bipolar depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.80
The LLM output is mostly correct in summarizing the effects of ketamine on treatment-resistant unipolar and bipolar depression, but it misses the mention of the ground truth that ketamine has effects on these types of depression, not just treats them.",0.8
"Sertraline Comparable to Escitalopram in terms of balance between benefits, acceptability, and acquisition cost for treating Major Depression",Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output provides information on specific medications for treating major depression, which is related to the ground truth statement about pharmacotherapy treating the acute phase of depression, but does not directly match.",0.75
Vagus Nerve Stimulation (VNS) treatment options resistant depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly mentions Vagus Nerve Stimulation (VNS) as a treatment option for resistant depression, but it does not accurately reflect the full range of somatic treatments typically used, leading to a slightly lower score.",0.75
"Mirtazapine, Escitalopram, Venlafaxine, Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output includes some correct antidepressants but does not fully match the ground truth statement which specifically mentions rTMS as being more effective than antidepressants in general.",0.75
Reboxetine Less effective all the other antidepressants tested,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output is only partially correct as it focuses on the effectiveness of Reboxetine compared to other antidepressants tested, while the ground truth statement discusses the effectiveness of rTMS compared to antidepressants in general.",0.5
Electroconvulsive therapy (ECT) most effective somatic therapy for depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.80
The LLM output correctly identifies electroconvulsive therapy (ECT) as an effective somatic treatment for depression, but it does not mention other widely used options like rTMS, tDCS, VNS, DBS, or magnetic seizure therapy.",0.8
Sertraline Comparable to Escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM output is partially correct because while it correctly identifies two SSRIs, it does not match the specific drugs mentioned in the ground truth statement.",0.5
Physical exercise recommendation as adjunct to other anti-depressive treatments,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.95
The LLM output is highly correct as it accurately captures the essence and message of the ground truth statement with slight rearrangement in wording.",0.95
TCAs More effective severe Major Depressive Disorder (MDD) symptoms in hospitalized patients,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies TCAs as being more effective for severe MDD symptoms in hospitalized patients, but does not directly address the comparison with rTMS and antidepressants mentioned in the ground truth.",0.75
Escitalopram and Sertraline Side effects significantly fewer discontinuations,Fluvoxamine Side effects Lower acceptability due to reduced efficacy,"Score: 0.75
The LLM output is mostly correct but misses the specific mention of Fluvoxamine and makes a minor mistake by stating ""fewer discontinuations"" instead of ""lower acceptability.""",0.75
Duloxetine and Paroxetine Side effects less well tolerated than Escitalopram and Sertraline,Duloxetine Side effects Lower acceptability,"Score: 0.75
The LLM output contains accurate information about the side effects of duloxetine and paroxetine, but it adds additional drugs and does not specifically mention acceptability.",0.75
Interpersonal therapy (IPT) Comparable to CBT for mild to moderate major depressive episodes in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.80
The LLM output is mostly correct, as it correctly identifies Interpersonal therapy (IPT) as a comparable treatment to CBT for mild to moderate major depressive episodes in adults, but it does not specifically mention ""depression-focused psychotherapy"" as indicated in the Ground Truth.",0.8
Reboxetine Not effective routine first-line acute treatment for major depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output is mostly correct in stating that reboxetine is not an effective first-line treatment for major depression, but it does not directly address the eligibility of monoamine oxidase inhibitors for patients who do not respond to other treatments.",0.75
"Anxious depression More common than nonanxious depression in African American group, Hispanics, Primary Care Patients, Unemployed, Married then Divorced/Widowed, Less Education, Public insurance, Lower-income","Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output contains information that is somewhat related to the ground truth, but it focuses more on demographic factors associated with anxious depression rather than problem-solving therapy for preventing depression among the elderly.",0.5
Citalopram first-line treatment Major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.25
The LLM output is not very correct as it does not accurately reflect the goal of mindfulness-based cognitive therapy for reducing depressive recurrence without increasing the risk of relapse.",0.25
Anxious depression Definition Major depressive disorder with clinically meaningful levels of anxiety,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is related to depression but does not directly match the ground truth statement, as it focuses on anxious depression rather than depression-focused psychotherapy.",0.5
"Anxious depression Symptom greater severity of depressive illness, greater functional impairment, greater illness chronicity, increased risk of suicidality",SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output provides relevant information about the characteristics of anxious depression but does not directly address the statement about SSRIs treating the acute phase of depression.",0.75
Escitalopram and Sertraline Highly effective moderate to severe major depression in adults,"SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly identifies Escitalopram and Sertraline as two of the medications included in the SSRI class, but the statement about their effectiveness in treating depression is not directly related to the ground truth.",0.75
Anxious depression Associated with poor acute outcome following antidepressant treatment compared to nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in describing the association between anxious depression and poor response to antidepressant treatment, although it does not specifically mention the slower response as stated in the ground truth.",0.75
Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) first-line treatment mild to moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output captures the essence of the ground truth statement but could be slightly improved with more specific language such as ""Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) are recommended as first-line treatments for mild to moderate Major Depressive Disorder.""",0.9
"Anxious depression side effects high mean QIDS-SR score at exit, low raw QID-SR change score, low percentage change in QIDS-SR score than nonanxious depression",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output provides relevant information and context about the relationship between anxious depression, side effects, and QIDS-SR scores, but does not directly mention suicidal behavior.",0.75
Mindfulness-Based Cognitive Therapy (MBCT) Potential alternative  to reduce or even stop antidepressant treatment without increasing the risk of depressive recurrence,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.90
The LLM output is mostly correct in summarizing the goal of Mindfulness-based cognitive therapy, but could be more specific in terms of being an alternative to antidepressant treatment.",0.9
Transcranial Direct Current Stimulation (tDCS) less effective than antidepressants and Repetitive Transcranial Magnetic Stimulation (rTMS) for the acute treatment of major depression,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 1.00
The LLM output accurately captures the essence of the ground truth statement by stating that tDCS is less effective than both antidepressants and rTMS for treating major depression.",1.0
Anxious depression Less commonly used adequate dose of citalopram due to side effects or patient’s choice,Depression Side effect Slower response to treatment,"Score: 0.60
The LLM output is somewhat related to the ground truth by mentioning depression and side effects, but it does not directly address the slower response to treatment mentioned in the ground truth.",0.6
Anxious depression Side effects greater reduction in anxiety/somatization score yet greater residual symptoms of anxiety/somatization than nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output partially captures the essence of the ground truth by mentioning anxiety symptoms and slower response to treatment in depression, but it introduces the concept of reduction in anxiety/somatization score without clearly stating the slower response to treatment.",0.75
